News
Aspira Pathlab & Diagnostics reports standalone net loss of Rs 1.16 crore in the September 2026 quarter
07-Nov-2026 | 07:44
Sales decline 22.62% to Rs 6.26 crore
Net loss of Aspira Pathlab & Diagnostics reported to Rs 1.16 crore in the quarter ended September 2026 as against net profit of Rs 1.84 crore during the previous quarter ended September 2025. Sales declined 22.62% to Rs 6.26 crore in the quarter ended September 2026 as against Rs 8.09 crore during the previous quarter ended September 2025.
| Particulars | Quarter Ended | ||
| Sep. 2026 | Sep. 2025 | % Var. | |
| Sales | 6.26 | 8.09 | -23 |
| OPM % | -10.86 | 27.19 | - |
| PBDT | -0.70 | 2.24 | PL |
| PBT | -1.16 | 1.84 | PL |
| NP | -1.16 | 1.84 | PL |
Powered by Capital Market - Live News